Roche’s Phase III Alzheimer’s antibody trials fail to meet primary endpoint
Switzerland
Novartis’ Phase III prostate cancer therapy trial meets primary endpoint
Assessing overall survival, which is the crucial secondary endpoint of the trial, is progressing.
Kinarus to discontinue Phase II trial of Covid-19 treatment
Kinarus doses first subject in Phase II Covid-19 drug combination trial
Roche’s subcutaneous Tecentriq meets Phase III NSCLC co-primary endpoints
ADC Therapeutics begins dosing Phase Ib non-Hodgkin lymphoma study
SGS Health implements Veeva’s application for streamlined trial design
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
